Skip to main content
Clinical Trials/NCT03057080
NCT03057080
Completed
Not Applicable

Peripheral Angioplasty as the First Choice Revascularization Procedure to Promote Ischemic Leg Ulcer Healing

University of Crete0 sites161 target enrollmentJune 1, 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischemic Foot Ulcers
Sponsor
University of Crete
Enrollment
161
Primary Endpoint
Number of patients with ulcer healing
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim of our study was to evaluate the technical and clinical effectiveness of PTA in the management of ischemic foot ulcers. All consecutive patients presenting with a foot ulcer at the outpatient Vascular surgery clinic of our hospital were evaluated. If non-invasive parameters suggested peripheral arterial disease (PAD) anatomic imaging (CTA and/or DSA) was performed and a PTA was carried out when feasible during the same session. All patients were followed until healing, amputation, death, or for at least two years. Short-term and long-term clinical success of PTA was evaluated based on ulcer size and appearance. Patients with worsening ulcers after PTA underwent bypass grafting or amputation.

Detailed Description

The aim of our study was to evaluate the technical and clinical effectiveness of PTA in the management of ischemic foot ulcers. Methods: All consecutive patients presenting with a foot ulcer at the outpatient Vascular surgery clinic of our hospital were evaluated. Preoperative evaluation included foot pulse assessment, ankle-brachial-index (ABI) and duplex scanning. If non-invasive parameters suggested peripheral arterial disease (PAD) anatomic imaging (CTA and/or DSA) was performed and a PTA was carried out when feasible during the same session. All patients were followed until healing, amputation, death, or for at least two years. Short-term and long-term clinical success of PTA was evaluated based on ulcer size and appearance. Patients with worsening ulcers after PTA underwent bypass grafting or amputation.

Registry
clinicaltrials.gov
Start Date
June 1, 2009
End Date
December 1, 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Izolde Bouloukaki

MD, PhD

University of Crete

Eligibility Criteria

Inclusion Criteria

  • newly diagnosed patients with ischemic foot ulcer and
  • patients aged 18 years or older.

Exclusion Criteria

  • refusal to participate
  • refusal of PTA therapy
  • lesions not amenable to endovascular revascularization by vascular team's consensus based on preinterventional imaging
  • absolute contraindication to contrast media injection, as determined by the investigator
  • uncontrollable coagulopathy
  • unwilling or unable to provide informed consent or return for required follow-up evaluations and
  • previous or concurrent participation in another clinical research study

Outcomes

Primary Outcomes

Number of patients with ulcer healing

Time Frame: 2 years

Number of patients with complete Ischemic leg ulcer healing defined as the complete epithelization of the lesion

Secondary Outcomes

  • Number of participants with Major adverse events(2 years)
  • Amputation free survival(2 years)
  • Number of patients with 30-day morbidity and mortality(30 days)
  • Number of patients requiring re-intervention(2 years)
  • Number of patients with all-cause mortality(2 years)

Similar Trials